As well as often being fragmented, big health data is of varying quality, incompatible in format and governed by disparate rules. This makes it harder to use and stifles the potential of AI, leading to lost opportunities in terms of competitiveness and research partnerships. The Lymphoma Data Hub aims to provide solutions to the problems encountered in lymphoma R&D projects.
